Loading
PH
Park Ha Biological Technology Co., Ltd. Stock: price and insider trades · United States
US·Mcap US$42.9M
Park Ha Biological Technology Co., Ltd.: what insiders have been doing
Park Ha Biological Technology Co., Ltd. has a thin disclosure history in our data (latest filing: 7 August 2026). New filings will appear here as soon as they are published. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,854 of 24,166 companies
35.5
score / 100
Value22
Quality49
FCF yld-0.0%
Earn yld-57%
EV/EBITDA·
ROE-113%
Gross mgn94%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended October 2025 · cache
US$2.20
Analyst consensus
Income statement
RevenueUS$2.5M
Gross profitUS$2.4M94% margin
EBITDA-US$24M-950% margin
Net income-US$24.4M-214.2% margin
Valuation
P/Book0.3x
Balance sheet & cash
Market capUS$42.9M
Total debtUS$180.2k
Free Cash Flow-US$3k
Debt / Equity3%
Profitability & ownership
ROE-113.0%
ROA-50.7%
% insiders30.1%
% institutions0.2%
Last declaration on 7 August 2026
Declarations1 total
112,500 shares@ US$0.180.018% mcap100.0% of flowClass A Ordinary SharesSEC:0001213900-26-086433:0
1 of 1 declaration
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. is a company focused on the development of biological technologies. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
